Guardant Health Management
Management criteria checks 4/4
Guardant Health's CEO is Helmy Eltoukhy, appointed in Jan 2013, has a tenure of 11.25 years. total yearly compensation is $11.63K, comprised of 0.01% salary and 100% bonuses, including company stock and options. directly owns 1.99% of the company’s shares, worth $39.14M. The average tenure of the management team and the board of directors is 3.1 years and 3.3 years respectively.
Key information
Helmy Eltoukhy
Chief executive officer
US$11.6k
Total compensation
| CEO salary percentage | 0.009% |
| CEO tenure | 11.3yrs |
| CEO ownership | 2.0% |
| Management average tenure | 3.1yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Mar 29
With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For
Jan 21Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Nov 20Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?
Sep 26A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)
Sep 05Is Guardant Health (NASDAQ:GH) A Risky Investment?
Aug 15A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)
May 28Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Apr 05Is Guardant Health (NASDAQ:GH) Using Too Much Debt?
Dec 28Guardant: Saving Lives One Blood Test At A Time
Oct 16Here's Why Guardant Health (NASDAQ:GH) Can Afford Some Debt
Aug 15Guardant Health's test gets FDA win for companion diagnostic to Enhertu's expanded use in lung cancer
Aug 12Guardant Health: Recent Developments Signal More Upsides
Jul 31Guardant Health: Pending Recession, May Hurt Cancer Care Demand
Jul 14Guardant Health (NASDAQ:GH) Is Carrying A Fair Bit Of Debt
Apr 29Guardant Health: Leaping Growth With Epic
Apr 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$479m |
| Sep 30 2023 | n/a | n/a | -US$432m |
| Jun 30 2023 | n/a | n/a | -US$508m |
| Mar 31 2023 | n/a | n/a | -US$665m |
| Dec 31 2022 | US$12k | US$1 | -US$655m |
| Sep 30 2022 | n/a | n/a | -US$606m |
| Jun 30 2022 | n/a | n/a | -US$551m |
| Mar 31 2022 | n/a | n/a | -US$419m |
| Dec 31 2021 | US$14k | US$1 | -US$406m |
| Sep 30 2021 | n/a | n/a | -US$409m |
| Jun 30 2021 | n/a | n/a | -US$379m |
| Mar 31 2021 | n/a | n/a | -US$336m |
| Dec 31 2020 | US$114m | US$210k | -US$254m |
| Sep 30 2020 | n/a | n/a | -US$185m |
| Jun 30 2020 | n/a | n/a | -US$120m |
| Mar 31 2020 | n/a | n/a | -US$77m |
| Dec 31 2019 | US$915k | US$500k | -US$76m |
| Sep 30 2019 | n/a | n/a | -US$76m |
| Jun 30 2019 | n/a | n/a | -US$87m |
| Mar 31 2019 | n/a | n/a | -US$97m |
| Dec 31 2018 | US$818k | US$480k | -US$85m |
| Sep 30 2018 | n/a | n/a | -US$75m |
| Jun 30 2018 | n/a | n/a | -US$84m |
| Mar 31 2018 | n/a | n/a | -US$83m |
| Dec 31 2017 | US$4m | US$460k | -US$89m |
Compensation vs Market: Helmy's total compensation ($USD11.63K) is below average for companies of similar size in the US market ($USD5.42M).
Compensation vs Earnings: Helmy's compensation has been consistent with company performance over the past year.
CEO
Helmy Eltoukhy (43 yo)
11.3yrs
Tenure
US$11,632
Compensation
Dr. Helmy Eltoukhy, Ph D., is Partner of Green Sands Equity Incorporated. He is Equity Partner and Advisor of Transform VC.Dr. Eltoukhy has been the Chairman of the Board of Directors of Guardant Health,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.3yrs | US$11.63k | 1.99% $ 39.1m | |
| Co-CEO & Director | 2.7yrs | US$11.18k | 2% $ 39.2m | |
| Chief Financial Officer | 3.3yrs | US$1.98m | 0.010% $ 201.2k | |
| Chief Legal Officer & Corporate Secretary | 3.9yrs | US$6.02m | 0.018% $ 354.0k | |
| Chief Medical Officer | 2.9yrs | US$3.62m | 0.0094% $ 185.1k | |
| Chief Commercial Officer | 2.8yrs | US$3.97m | 0.013% $ 258.1k | |
| Chief Technology Officer | no data | no data | 0.030% $ 586.7k | |
| Chief Information Officer | 4.3yrs | no data | 0.011% $ 222.3k | |
| Senior Vice President of Public Affairs | no data | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Senior Vice President of Regulatory & Quality | no data | no data | no data | |
| Vice President of Product Development | no data | no data | no data |
3.1yrs
Average Tenure
54yo
Average Age
Experienced Management: GH's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.3yrs | US$11.63k | 1.99% $ 39.1m | |
| Co-CEO & Director | 11.3yrs | US$11.18k | 2% $ 39.2m | |
| Independent Director | 2.5yrs | US$425.14k | 0.0062% $ 121.4k | |
| Lead Independent Director | 7.3yrs | US$470.17k | 0.0073% $ 143.8k | |
| Independent Director | 1.8yrs | US$725.15k | 0.0027% $ 52.3k | |
| Independent Director | 1.1yrs | no data | 0.0025% $ 48.4k | |
| Independent Director | 3.8yrs | US$425.14k | 0.0099% $ 194.7k | |
| Independent Director | 2.7yrs | US$425.14k | 0.0038% $ 74.2k |
3.3yrs
Average Tenure
45.5yo
Average Age
Experienced Board: GH's board of directors are considered experienced (3.3 years average tenure).